The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - AstraZeneca; Celgene; Lilly; Millennium
Ongoing phase 1/2 study of INCB050465 for relapsed/refractory (R/R) B-cell malignancies (CITADEL-101).
 
Rod Ramchandren
Consulting or Advisory Role - Curis; Gilead Sciences; Seagen
Research Funding - Janssen; Merck; Pharmacyclics
 
Tycel Jovelle Phillips
Consulting or Advisory Role - Pharmacyclics; Seagen
Travel, Accommodations, Expenses - Incyte
 
Michael Wertheim
No Relationships to Disclose
 
Martin Gutierrez
Stock and Other Ownership Interests - COTA
Consulting or Advisory Role - Bayer; Karyopharm Therapeutics; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Foundation One Inc; Merck
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Esanex (Inst); Gilead Sciences (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Rexahn Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
William Jeffery Edenfield
Speakers' Bureau - Astellas Medivation; Novartis
 
Luke Paul Akard
Consulting or Advisory Role - Novartis
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Gilead Sciences; Millennium; Novartis; Teva
Research Funding - Astellas Medivation; Cellerant; Incyte; Pfizer; Teva; Unum Therapeutics
 
Paolo Fabrizio Caimi
Stock and Other Ownership Interests - Abbvie; Incyte; Seagen
Speakers' Bureau - Celgene
 
Justin Call
No Relationships to Disclose
 
Daniel Oscar Persky
Consulting or Advisory Role - Cardinal Health; Genentech; MorphoSys; Spectrum Pharmaceuticals; Verastem
Speakers' Bureau - Gilead Sciences
Research Funding - Merck (Inst)
 
Douglas James DeMarini
Employment - GlaxoSmithKline; Incyte
Stock and Other Ownership Interests - GlaxoSmithKline; Incyte
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Li Zhou
Employment - Incyte; Merck (I)
Stock and Other Ownership Interests - Incyte; Merck (I)
 
Swamy Yeleswaram
Employment - Incyte (I)
Stock and Other Ownership Interests - Incyte
Travel, Accommodations, Expenses - Incyte
 
Andres Forero-Torres
Speakers' Bureau - Seagen
Research Funding - Daiichi Sankyo (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Seagen (Inst); Syndax (Inst); TRACON Pharma (Inst)